CD86 Antibody

Activation B7-2 antigen; B lymphocyte activation antigen B72; CD28 antigen ligand 2; CD28LG2; CLS1; CTLA-4 counter-receptor B7.2; Early T-cell co-stimulatory molecule 1; ETC-1; FUN-1; LAB72; Ly-58; MB7-2; TS/A-2

200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% rAlbumin & 0.05% azide. Also available WITHOUT rAlbumin & azide at 1.0mg/ml.

Bing Lu et al. Targeting the tumor microenvironment: reprogramming macrophages as a novel therapeutic strategy in FUOM-deficient glioblastoma Cell Death Dis ., (2026), Qiming Gu1 Jiali Shan1 Yan Li2 Zhengyi Lian1 Tang Liu1 Lei Yang2 Bingyi Liu1 Kefan Wu1 Xuan Li1 Qichao Ni1 Jun Fang1 DAPP1 Elevated Expression Influences Macrophages and Predicts Poor Prognosis in Breast Cancer researchsquare.com, (2025), Yu X., Xu L., Zhou Y., Zhou X, Yang L., Zhou Y. NUP62CL as an Immunological and Prognostic Biomarker of Oral Squamous Cell Carcinoma Dove Medical Press, 16, 3799-3809 (2023), Saba Ahangaran, Arash Pourgholaminejad, Rahim Nosrati, Parvin Babaei TLR4 inhibition attenuates facilitatory effects of JQ1 on learning & memory via polarization of microglia, and BDNF expression in Alzheimer's disease model Behav Brain Res, 499, 115919 (2026), Guying He et al. Vesicle trafficking 1 in breast cancer tissue and serum orchestrates metastatic progression and an immunosuppressive microenvironment Int Immunopharmacol, (2026)